Notice - Prescription Drug List (PDL): Levonorgestrel
Description
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for levonorgestrel on the Prescription Drug List (PDL). Only the Human part of the PDL was revised; the listing for Veterinary use will remain unchanged.
Resources
| Name |
Format |
Description |
Link |
|
21 |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-levonorgestrel.html |
|
21 |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-levonorgestrel.html |